Severe Community-Acquired Bloodstream Infection with Acinetobacter ursingii in Person who Injects Drugs

Emerg Infect Dis. 2016 Jan;22(1):134-7. doi: 10.3201/eid2201.151298.

Abstract

We report a community-acquired bloodstream infection with Acinteobacter ursingii in an HIV-negative woman who injected drugs. The infection was successfully treated with meropenem. Species identification was performed by using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Improved identification of Acinetobacter spp. by using this method will help identify clinical effects of this underdiagnosed pathogen.

Keywords: Acinetobacter ursingii; MALDI-TOF; bacteria; community-acquired bloodstream infection; matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; person who injects drugs; severe sepsis.

Publication types

  • Case Reports

MeSH terms

  • Acinetobacter / drug effects
  • Acinetobacter / pathogenicity*
  • Acinetobacter Infections / drug therapy
  • Acinetobacter Infections / microbiology*
  • Bacteremia / drug therapy
  • Bacteremia / microbiology*
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / microbiology*
  • Female
  • Humans
  • Meropenem
  • Middle Aged
  • Thienamycins / therapeutic use

Substances

  • Thienamycins
  • Meropenem